Additional info
| COMPOSITION | Highly purified and fractionated Panax notoginseng and Astragalus membranaceus produced by a proprietary pharmaceutical extraction and processing technology. |
| AVAILABE IN | Italy, Poland, Iberia |
| FORMULATION & DOSAGE | Clinical dosage 50mg; EFSA suggested dosage: 35mg |
| DELIVERY FORMS |
|